Quantcast
Last updated on April 18, 2014 at 11:20 EDT

Latest Statin Stories

2014-03-28 08:26:53

U.S. Healthcare Professionals Now Can Perform Lab-Accurate Lipid and Liver Diagnostics with a simple fingerstick using the Piccolo® Blood Chemistry Analyzer. UNION CITY, Calif., March 28, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Food and Drug Administration granted CLIA waived status for capillary draw for CHOL, HDL and TRIG. Combined with existing CLIA waived tests for...

Key To Curbing Lifetime Heart Disease Risk Is Knowing True Age Of Your Heart
2014-03-27 13:31:06

BMJ-British Medical Journal Part of new risk assessment which aims to put patients in driving seat and start prevention early The Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3), which have been drawn up by 11 UK professional societies and charitable organizations, are based on the latest available scientific evidence. They emphasize the importance of putting patients in the driving seat and starting preventive action early on,...

2014-03-27 04:20:44

Companies to Host Investor Conference Call on Alirocumab on March 31 at 9 AM EDT PARIS and TARRYTOWN, N.Y., March 27, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from alirocumab clinical studies will be presented at the American College of Cardiology's (ACC) 63rd Annual Scientific Session in Washington, D.C. March 29-31. Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein...

2014-03-26 23:31:29

National network of attorneys continues to offer no-cost consultations to consumers over allegations that Lipitor and other statins increase the risk of developing diabetes. San Diego, CA (PRWEB) March 26, 2014 http://www.resource4thepeople.com/defectivedrugs/lipitor-lawsuit.html Resource4thePeople today announced an important legal update for consumers who are interested in litigation involving allegations that the anti-cholesterol medication Lipitor may cause patients to develop...

2014-03-25 23:03:54

The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statins. New York, New York (PRWEB) March 25, 2014 Hundreds of Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that allege use of the statin drug caused patients to develop new-onset Type 2 diabetes have begun to move forward in a multidistrict litigation underway in U.S. District Court, District of South Carolina. According to an Order...

2014-03-24 20:23:34

Five Phase 3 Studies With Evolocumab (AMG 145) to be Featured in Late-Breaking and Clinical Research Presentations - Data Form the Basis of Global Filing Plan THOUSAND OAKS, Calif., March 24, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present pivotal Phase 3 data from five clinical studies evaluating evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density...

Multiple Sclerosis May Benefit From Statins
2014-03-19 10:09:06

Brett Smith for redOrbit.com - Your Universe Online At first, multiple sclerosis is recognized by sporadic neurological symptoms – a condition called relapsing-remitting MS. Within a decade or so, greater than 50 percent of patients acquire secondary progressive MS, a continuous deterioration of symptoms and boost in disability. Currently, there are no approved drugs for treating this later stage of the disease. However, a newly published study in the UK medical journal The Lancet has...

2014-03-18 23:23:59

The United States Judicial Panel (USJP) on Multidistrict Litigation (MDL) has recently issued a transfer order that will remit 56 Lipitor lawsuits and many more tag-along actions to the District of South Carolina to facilitate this litigation. New York, NY (PRWEB) March 18, 2014 The attorneys at Alonso Krangle applaud the USJP’s recent transfer order that will consolidate many pending Lipitor lawsuits in an MDL that will take place in the District of South Carolina federal court (Case...

2014-03-18 23:02:01

The firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor. New York, New York (PRWEB) March 18, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to mount in federal court, Bernstein Liebhard LLP notes the publication of a new study that suggests an association between the use of statin drugs like Lipitor and the development of new-onset Type 2 diabetes. The research, which was...

2014-03-17 08:30:17

Study Meets Primary Endpoint of LDL Cholesterol Reduction THOUSAND OAKS, Calif., March 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C). The percent reduction in LDL-C, or "bad" cholesterol, was clinically meaningful and statistically...